Select a medication above to begin.
Repatha
evolocumab
Adult Dosing .
Dosage forms: INJ (SureClick auto-injector): 140 mg; INJ (pre-filled syringe): 140 mg per mL
cardiovascular event risk reduction
- [140 mg SC q2wk]
- Alt: 420 mg SC qmo; Info: for pts w/ established CVD
primary hyperlipidemia
- [140 mg SC q2wk]
- Alt: 420 mg SC qmo
heterozygous familial hypercholesterolemia
- [140 mg SC q2wk]
- Alt: 420 mg SC qmo
homozygous familial hypercholesterolemia, adjunct tx
- [420 mg SC qmo or 420 mg SC q2wk]
- Start: 420 mg SC qmo, may incr. to 420 mg SC q2wk after 12wk if inadequate response; Info: may start 420 mg SC q2wk if pt on lipid apheresis
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [see below]
- Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined
Peds Dosing .
- Dosage forms: INJ (SureClick auto-injector): 140 mg; INJ (pre-filled syringe): 140 mg per mL
heterozygous familial hypercholesterolemia, adjunct tx
- [10 yo and older]
- Dose: 140 mg SC q2wk; Alt: 420 mg SC qmo
homozygous familial hypercholesterolemia, adjunct tx
- [10 yo and older]
- Dose: 420 mg SC qmo or 420 mg SC q2wk; Start: 420 mg SC qmo, may incr. to 420 mg SC q2wk after 12wk if inadequate response; Info: may start 420 mg SC q2wk if pt on lipid apheresis
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [see below]
- Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined